PAPER Pedrero-Chamizo R, Zhuang K, Juarez A, Janabi M, Jagust WJ, Landau SM
SEARCH RESULTS
331395 RESULTS
PAPER Rotstein A
Adult-Onset Attention-Deficit/Hyperactivity Disorder and the Risk of Lewy Body Dementia: An Invited Commentary.
Am J Geriatr Psychiatry. 2024 Apr 10; PubMed: 38664081PAPER Korologou-Linden R, Xu B, Coulthard E, Walton E, Wearn A, Hemani G, White T, Cecil C, Sharp T, Tiemeier H, Banaschewski T, Bokde A, Desrivières S, Flor H, Grigis A, Garavan H, Gowland P, Heinz A, Brühl R, Martinot JL, Paillère Martinot ML, Artiges E, Nees F, Orfanos DP, Paus T, Poustka L, Millenet S, Fröhner JH, Smolka M, Walter H, Winterer J, Whelan R, Schumann G, Howe LD, Ben-Shlomo Y, Davies NM, Anderson EL
Genetics impact risk of Alzheimer's disease through mechanisms modulating structural brain morphology in late life.
J Neurol Neurosurg Psychiatry. 2024 Apr 25; PubMed: 38663994PAPER Carr LM, Mustafa S, Care A, Collins-Praino LE
More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease.
Brain Behav Immun. 2024 Apr 23; PubMed: 38663775PAPER Nozal V, Fernández-Gómez P, García-Rubia A, Martínez-González L, Cuevas EP, Carro E, Palomo V, Martínez A
Designing multitarget ligands for neurodegenerative diseases with improved permeability trough PLGA nanoencapsulation.
Biomed Pharmacother. 2024 Apr 24;175:116626. PubMed: 38663103PAPER Orlandi F, Carlos AF, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Stephens YC, Schwarz CG, Senjem ML, Jack CR, Agosta F, Filippi M, Dickson DW, Josephs KA, Whitwell JL
Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants.
Brain Commun. 2024;6(2):fcae113. Epub 2024 Apr 5 PubMed: 38660629PAPER Fu Y, Wang Y, Ren H, Guo X, Han L
Branched-chain amino acids and the risks of dementia, Alzheimer's disease, and Parkinson's disease.
Front Aging Neurosci. 2024;16:1369493. Epub 2024 Apr 10 PubMed: 38659706PAPER Wang S, Xie S, Zheng Q, Zhang Z, Wang T, Zhang G
Biofluid biomarkers for Alzheimer's disease.
Front Aging Neurosci. 2024;16:1380237. Epub 2024 Apr 10 PubMed: 38659704PAPER Mollah SA, Nayak A, Barhai S, Maity U
A comprehensive review on frontotemporal dementia: its impact on language, speech and behavior.
Dement Neuropsychol. 2024;18:e20230072. Epub 2024 Apr 22 PubMed: 38659629PAPER Yang LX, Luo M, Li SY
Tanshinone IIA improves Alzheimer's disease via RNA nuclear-enriched abundant transcript 1/microRNA-291a-3p/member RAS oncogene family Rab22a axis.
World J Psychiatry. 2024 Apr 19;14(4):563-581. PubMed: 38659601Robert Sobolewski
Massachusetts General HospitalCharlestown, United States
Thomas Foltynie on Diabetes Drug Shows Promise for Parkinson’s Disease
COMMENT This is an important publication, given it essentially replicates the findings of Athauda et al., who reported positive Phase 2 data of a very similar GLP-1 receptor agonist drug, exenatide, when given to patients with Parkinson’s disease (Athauda et al.,
Oscar Mailman
Pittsburgh, United States
Nazaret Gamez
Houston Methodist Research InstituteHouston, United States
Sandrine Legg
Alchemab Therapeutics
Current Filters
No filters selected